Status:
UNKNOWN
FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization.
Lead Sponsor:
Azienda Ospedaliera San Camillo Forlanini
Conditions:
Myocardial Infarction
Ischemia
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
Few reports described outcomes of complete compared with infarct related artery (IRA) only revascularization in patients with ST elevation myocardial infarction (STEMI) and multivessel coronary diseas...
Eligibility Criteria
Inclusion
- myocardial acute infarction
- prolonged chest pain (\>20 minute) started less \<12 hours before arrive in hospital
- ST segment elevation of \>1mm in \>2 contiguous leads
- new left bundle branch block
- diameter of the coronary suitable of angioplasty \>2mm
- the patients agrees to the study protocol and provides a written consensus
- two or more coronary suitable for angioplasty
Exclusion
- refused written consensus
- hypersensitivity or contraindication to any of the following medications: heparin bivalirudin aspirin prasugrel stainless steel
- history of bleeding
- cardiogenic shock (PA \< 90mmHg)
- chronic total occlusion in the second lesion
- TIMI Flow \< II in the culprit lesion
- recent pregnancy
- history of intra-cerebral major hemorrhagic stroke
- an elective surgical procedure is planned that would necessitate interruption of thienopyridines during the first six months post enrollment life expectancy \<1 year
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01160900
Start Date
July 1 2010
End Date
July 1 2012
Last Update
July 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera San Camillo Forlanini
Roma, Italy, Italy, 00151